Innovent Biologics (suzhou) Co. Ltd.

This early-phase study tests a new drug called IBI343 in people with advanced solid tumors that cannot be removed by surgery or have spread. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. About 470 participants will take part in mul…

This study tests whether a new drug called IBI363, when combined with chemotherapy, works better than the standard drug pembrolizumab with chemotherapy before surgery for people with a certain type of lung cancer (non-squamous, stage IB to III). About 170 adults aged 18 to 75 wil…

This study tests a new drug called IBI343 combined with other treatments for people with advanced stomach, gastroesophageal junction, or pancreatic cancers that have a specific protein (CLDN18.2). The goal is to see if the combination is safe and shrinks tumors. About 389 adults …

This study tests a new drug called IBI3013 in healthy volunteers and people with active vitiligo or severe alopecia areata. The goal is to check the drug's safety and how the body processes it. The study has two parts: one with healthy people lasting up to 24 weeks, and another w…

This study tests a new drug called IBI3014 in people with advanced solid tumors that cannot be removed by surgery or have spread. The main goals are to find a safe dose and see if the drug can shrink tumors. About 250 adults will take part in this early-phase trial.

This study tests whether adding the experimental drug IBI343 to standard chemotherapy and immunotherapy before and after surgery can improve outcomes for people with a certain type of advanced stomach or gastroesophageal junction cancer. About 90 adults whose tumors have a specif…

This study tests a new medicine called IBI362 to help Chinese teenagers aged 12 to 17 who are obese or overweight and have related health problems. The goal is to see if the drug safely reduces body mass index (BMI) compared to a placebo. Participants must have tried diet and exe…

This early-phase study tests a new drug called IBI115, alone or with other treatments, in 150 adults with advanced small cell lung cancer. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. Participants must have measurable cancer and b…

This study tests a new medicine called IBI306 in about 198 adults with high cholesterol (not inherited) or mixed high cholesterol and fats. Participants receive either the drug or a placebo as a shot, and doctors check how much their bad cholesterol drops over 12 weeks. The goal …

This study tests an experimental drug called IBI311 for people with inactive thyroid eye disease, a condition that causes the eyes to bulge. The goal is to see if the drug can safely reduce eye bulging by at least 2 millimeters. About 111 adults will receive either IBI311 or a pl…

This study tests a new medicine called IBI362 for people with a serious liver condition known as MASH (fatty liver with inflammation and scarring). About 165 adults with MASH and moderate-to-severe liver scarring will receive either a low or high dose of IBI362 or a placebo for 6…

This study tests an experimental drug called IBI3002 in 120 adults with moderate to severe atopic dermatitis (eczema). The goal is to see if it reduces skin redness, thickness, and itching better than a placebo over 16 weeks. Participants will be randomly assigned to receive eith…

This study tests an experimental drug called IBI356 in 403 adults with moderate to severe atopic dermatitis (eczema). The goal is to see if it reduces skin redness, itching, and rash better than a placebo. Participants must have had eczema for at least a year and not responded we…